novolin 70/30
Generic: human insulin
Labeler: novo nordiskDrug Facts
Product Profile
Brand Name
novolin 70/30
Generic Name
human insulin
Labeler
novo nordisk
Dosage Form
INJECTION, SUSPENSION
Routes
Active Ingredients
insulin human 100 [iU]/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0169-1837
Product ID
0169-1837_c7164ea1-aa3e-4359-a3f0-a34c78e78398
Product Type
HUMAN OTC DRUG
Marketing Category
BLA
Application Number
BLA019991
Listing Expiration
2026-12-31
Marketing Start
1991-06-25
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01691837
Hyphenated Format
0169-1837
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
novolin 70/30 (source: ndc)
Generic Name
human insulin (source: ndc)
Application Number
BLA019991 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 [iU]/mL
Packaging
- 1 VIAL in 1 CARTON (0169-1837-02) / 10 mL in 1 VIAL
- 1 VIAL in 1 CARTON (0169-1837-11) / 10 mL in 1 VIAL
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "c7164ea1-aa3e-4359-a3f0-a34c78e78398", "openfda": {"nui": ["M0011417", "N0000175944"], "unii": ["1Y17CTI5SR"], "rxcui": ["213442", "311048", "847187", "2049380"], "spl_set_id": ["508a2763-3cb7-4be5-9e53-544e84cd9b1f"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin [EPC]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0169-1837-02) / 10 mL in 1 VIAL", "package_ndc": "0169-1837-02", "marketing_start_date": "19910625"}, {"sample": false, "description": "1 VIAL in 1 CARTON (0169-1837-11) / 10 mL in 1 VIAL", "package_ndc": "0169-1837-11", "marketing_start_date": "19910625"}], "brand_name": "Novolin 70/30", "product_id": "0169-1837_c7164ea1-aa3e-4359-a3f0-a34c78e78398", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Insulin [CS]", "Insulin [EPC]"], "product_ndc": "0169-1837", "generic_name": "Human Insulin", "labeler_name": "Novo Nordisk", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Novolin", "brand_name_suffix": "70/30", "active_ingredients": [{"name": "INSULIN HUMAN", "strength": "100 [iU]/mL"}], "application_number": "BLA019991", "marketing_category": "BLA", "marketing_start_date": "19910625", "listing_expiration_date": "20261231"}